Rapamycin Inhibits Akt-Mediated Oncogenic Transformation and Tumor Growth by Liu, Xuesong, Powlas, Jessica, Shi, Yan, Oleksijew, Anatol X, Shoemaker, Alexander R, De Jong, Ron, Oltersdorf, Tilman, Giranda, Vincent L, Luo, Yan

Get full text

Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers by Zhu, Gui-Dong, Gandhi, Viraj B., Gong, Jianchun, Luo, Yan, Liu, Xuesong, Shi, Yan, Guan, Ran, Magnone, Shayna R., Klinghofer, Vered, Johnson, Eric F., Bouska, Jennifer, Shoemaker, Alexander, Oleksijew, Anatol, Jarvis, Ken, Park, Chang, Jong, Ron De, Oltersdorf, Tilman, Li, Qun, Rosenberg, Saul H., Giranda, Vincent L.

Get full text

Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo by Shi, Yan, Liu, Xuesong, Han, Edward K., Guan, Ran, Shoemaker, Alexander R., Oleksijew, Anatol, Woods, Keith W., Fisher, John P., Klinghofer, Vered, Lasko, Loren, McGonigal, Thomas, Li, Qun, Rosenberg, Saul H., Giranda, Vincent L., Luo, Yan

Get full text

Isoquinoline–pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activity by Zhu, Gui-Dong, Gong, Jianchun, Claiborne, Akiyo, Woods, Keith W., Gandhi, Viraj B., Thomas, Sheela, Luo, Yan, Liu, Xuesong, Shi, Yan, Guan, Ran, Magnone, Shayna R., Klinghofer, Vered, Johnson, Eric F., Bouska, Jennifer, Shoemaker, Alexander, Oleksijew, Anatol, Stoll, Vincent S., Jong, Ron De, Oltersdorf, Tilman, Li, Qun, Rosenberg, Saul H., Giranda, Vincent L.

Get full text